Suppression of Hepatic CYP3A4 Expression and Activity by 3-Methylcholanthrene in Humanized PXR-CAR-CYP3A4/3A7 Mice

Drug Metabolism and Disposition - United States
doi 10.1124/dmd.118.084509
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Effects of Oridonin on Hepatic Cytochrome P450 Expression and Activities in PXR-Humanized Mice

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2018English

Nuclear Receptors CAR and PXR in the Regulation of Hepatic Metabolism

Xenobiotica
PharmacologyBiochemistryMutagenesisHealthMedicineToxicology
2006English

The CYP3A4 Intron 6 C>T Polymorphism (CYP3A4*22) Is Associated With Reduced CYP3A4 Protein Level and Function in Human Liver Microsomes

Journal of Toxicological Sciences
MedicineToxicology
2013English

Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4

AAPS Journal
Pharmaceutical Science
2019English

Continuum of Host-Gut Microbial Co-Metabolism: Host CYP3A4/3A7 Are Responsible for Tertiary Oxidations of Deoxycholate Species

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2019English

Regulation of Hepatic Long Non-Coding RNAs by PXR and CAR Agonists in Mouse Liver

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2018English

Substrate-Specific Modulation of CYP3A4 Activity by Genetic Variants of Cytochrome P450 Oxidoreductase

Pharmacogenetics and Genomics
Molecular MedicineGeneticsMolecular Biology
2010English

Mitotane Induces CYP3A4 Expression via Activation of the Steroid and Xenobiotic Receptor

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2012English

Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Tamoxifen Metabolism

European Journal of Clinical Pharmacology
MedicinePharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy